MYL5 and ovarian serous cystadenocarcinoma: Because there were no matched normal tissues for adrenocortical carcinoma (ACC), lymphoid neoplasm diffuse large B-cell lymphoma (DLBC), acute myeloid leukemia (LAML), brain lower grade glioma (LGG), ovarian serous cystadenocarcinoma (OV), sarcoma (SARC), skin cutaneous melanoma (SKCM), testicular germ cell tumors (TGCG), thymoma (THYM), and uterine carcinosarcoma (UCS), we further investigated the differential expression of MYL5 between tumors and normal tissues by using the GEPIA 2 tools to match TCGA normal and GTEx data.